In-Person Registration for Industry Professionals | Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia.